Skip to content
Search

Latest Stories

CPE asks for ‘inputs’ on winter pressure from independents and non-CCA

Community pharmacy owners to share their views in the new survey

Community Pharmacy England (CPE) is seeking views from all community pharmacy owners about the pressures faced this autumn season.


A survey has been launched as the “November Pre-Committee Opinion Poll” until 6 November to seek views from independents and non-Company Chemists’ Association (CCA) members.

The results of the poll will be sent to the head offices of CCA multiples next week for discussion at the November Committee Meeting.

CPE confirmed: "The results of these polls and the outcomes of the meeting will be reported back to the sector afterwards.

They said that the survey "will be used to feed into our ongoing work to press for an uplift to core funding by enhancing our evidence base of what pharmacy owners are experiencing."

"This and future surveys will also increase the amount of data we have for use in our campaigning and influencing work,” CPE added.

The Committee meeting will discuss progress in negotiations, focusing on the 2024-2025 Community Pharmacy Contractual Framework (CPCF) and the future strategy for Community Pharmacy England.

It is guided by the recently published Vision for Community Pharmacy report by The King's Fund and the Nuffield Trust.

“This new approach to engagement aims to help us to build stronger relationships with pharmacy owners by improving how we engage with the sector and listening to pharmacy’s views better,” CPE further added.

The community pharmacies have been facing unsustainable pressures through the autumn period.

In the statement, CPE also assures that they are also tracking the financial pressures on community pharmacies.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less